The U.S. orthopedic surgical robotics market is witnessing strong growth as hospitals and healthcare providers increasingly adopt robotic-assisted systems for knee and hip surgeries. The market is being driven by rising orthopedic procedure volumes, growing demand for precision-based surgery, and continuous advancements in robotic surgical platforms.
According to the shared market data, the U.S. orthopedic surgical robotics market grew from $531.1 million in 2020 and is projected to reach $1,263.1 million by 2026. The rapid expansion highlights the increasing importance of robotic-assisted orthopedic procedures in the U.S. healthcare system.
Several factors are supporting the growth of the orthopedic surgical robotics market in the United States:
• Increasing adoption of robotic-assisted knee and hip replacement surgeries
• Rising demand for minimally invasive orthopedic procedures
• Growing geriatric population requiring joint replacement procedures
• Higher precision and consistency offered by robotic systems
• Expansion of installed robotic surgical systems across hospitals
The market is heavily concentrated around knee procedures, particularly total knee arthroplasty (TKA), which remains the largest application area for orthopedic robotics.
Track U.S. orthopedic procedure volumes by application, region, and state.
- Explore Surgical Procedure Volume Database
%20(by%20Company).png)
Company | Surgical System | Surgical Application |
Stryker Corporation | Mako System | TKA, PKA, THA |
Zimmer Biomet Holdings, Inc. | ROSA Knee System | TKA |
Smith & Nephew plc | Navio System | TKA, PKA |
Smith & Nephew plc | Cori System | TKA, PKA |
THINK Surgical, Inc. | TSolution One System | TKA, PKA |
Corin Group | OMNIBotics System | TKA |
AOT AG | CARLO System | Orthopedic surgeries |
Jianjia Robots | Arthrobot System | Orthopedic surgeries |
CUREXO, Inc. | CUVIS-Joint System | Joint surgeries |
Monogram Orthopedics | Monogram System | Orthopedic surgeries |
Need company-level market sizing or competitive insights? Request a quote today.
Stryker Corporation is the clear leader in the U.S. orthopedic surgical robotics industry. The company’s Mako System has established a strong presence across total knee arthroplasty, partial knee arthroplasty, and total hip arthroplasty procedures.
In 2020, Stryker accounted for 68.3% market share, significantly ahead of other competitors in the orthopedic robotics market. The company’s total market revenue increased from $362.7 million in 2020 to $714.8 million in 2026, reflecting strong adoption of its robotic-assisted surgical platform.
Stryker also maintained the largest installed base in the market. Its installed systems increased from 890 systems in 2020 to 1,980 systems by 2026, highlighting its expanding hospital footprint across the U.S.
The company’s strong positioning in both knee and hip robotic procedures gives it a competitive advantage over companies focused only on knee applications.
Smith & Nephew has strengthened its position in the orthopedic robotics market through its Navio System and Cori System. Both robotic platforms primarily focus on knee procedures, including total knee arthroplasty and partial knee arthroplasty.
The company experienced substantial growth between 2020 and 2026. Its revenue increased from $68.8 million in 2020 to $200.7 million in 2026. At the same time, its installed base expanded from 404 systems to 1,115 systems.
The rapid growth of Smith & Nephew indicates rising acceptance of robotic-assisted knee surgery solutions among healthcare providers.
See how market intelligence can help track surgical robotics adoption and competitor performance- Schedule a Demo
Zimmer Biomet Holdings, Inc. remains one of the major competitors in the U.S. orthopedic surgical robotics market through its ROSA Knee System.
The company’s revenue increased steadily from $56.4 million in 2020 to $143.8 million by 2026. Its installed base also rose significantly from 110 systems in 2020 to 550 systems in 2026.
Zimmer Biomet continues to strengthen its position in robotic knee replacement procedures as hospitals increase investments in advanced orthopedic surgical technologies.
While Stryker, Smith & Nephew, and Zimmer Biomet dominate the market, smaller companies are also gaining traction.
Corin Group’s revenue increased from $17.6 million in 2020 to $76.9 million in 2026, supported by its OMNIBotics System. THINK Surgical also demonstrated steady growth, with revenue rising from $17.8 million to $64.2 million during the same period.
The presence of these companies highlights the increasing competition and innovation within the orthopedic surgical robotics industry.
The growth of the U.S. orthopedic surgical robotics market is closely linked to the increasing number of robotic-assisted orthopedic procedures performed annually.
Total procedure volume increased from 123.5 thousand procedures in 2020 to 483.6 thousand procedures in 2026.
Knee procedures represented the largest share of the market, growing from 92.7 thousand procedures in 2020 to 377.2 thousand procedures in 2026. Hip procedures also expanded significantly, increasing from 30.8 thousand to 106.4 thousand during the same period.
This growth reflects increasing surgeon confidence in robotic-assisted orthopedic surgery and rising patient demand for technologically advanced surgical procedures.
The Southern United States emerged as the leading regional market for orthopedic robotic procedures. Procedure volume in the South increased from 48.64 thousand procedures in 2020 to 193.84 thousand procedures in 2026.
The Western region also experienced strong growth, increasing from 29.75 thousand to 118.20 thousand procedures. Meanwhile, the Midwest and Northeast regions also showed consistent expansion.
At the state level, California remained the largest market for orthopedic robotic procedures, followed by Texas and Florida. California’s procedure volume increased from 17.72 thousand procedures in 2020 to 69.36 thousand procedures in 2026.
The competitive landscape of the U.S. orthopedic surgical robotics market remains highly concentrated, with Stryker maintaining a dominant leadership position. However, the increasing adoption of robotic-assisted orthopedic surgery is creating opportunities for companies such as Smith & Nephew, Zimmer Biomet, Corin Group, and THINK Surgical.
As hospitals continue investing in robotic surgical platforms and orthopedic procedure volumes rise, competition among leading medical technology companies is expected to intensify further.
The market’s strong growth trajectory between 2020 and 2026 demonstrates that robotic-assisted orthopedic surgery is becoming a major component of modern orthopedic care in the United States.
